Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma.
about
Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: An NRG Oncology/Gynecologic Oncology Group ancillary analysis.Whole-Genome DNA Methylation Profiling Identifies Epigenetic Signatures of Uterine CarcinosarcomaESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up.The Use of Lattice Radiation Therapy (LRT) in the Treatment of Bulky Tumors: A Case Report of a Large Metastatic Mixed Mullerian Ovarian TumorA strategy to combine pathway-targeted low toxicity drugs in ovarian cancerPrimary Ovarian Malignant Mixed Mullerian Tumour: A Case Report and Brief Review of Literature.Pazopanib as a second line treatment for uterine and ovarian carcinosarcoma: a single institutional study.Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma.The anti-cancer effects of itraconazole in epithelial ovarian cancerKRAS mutation coupled with p53 loss is sufficient to induce ovarian carcinosarcomas in mice.Synchronous endometrial adenocarcinoma and carcinosarcoma in endometrial polyp.Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site.Prognostic significance of lymph node metastasis and lymphadenectomy in early-stage ovarian carcinosarcoma.ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-upResponse to pembrolizumab in a heavily treated patient with metastatic ovarian carcinosarcoma
P2860
Q36164445-66038252-9EFE-4E77-B536-AEF820CFBFDDQ36249984-C75C78CC-5AA7-4E6C-AFDB-76111B193B3CQ36372293-8F1BC871-642E-4709-AEDA-3F7A67F84AA6Q36399658-88A2EC84-50D8-4DB0-945C-B8F7A0DD7BCFQ36544506-E36A399E-D046-4770-BBCA-282A44AF957AQ36831208-7C890C71-680E-4D9D-B86A-2400FB29555CQ37512369-FD3CE0EC-AF0A-45A8-84A4-FE826A293E57Q38381194-F7292207-C47F-4ECC-AE3C-7A636DE0AB1DQ38696316-D0D37D02-9D53-4530-B344-1BF6B500AD34Q38723863-46858784-1AE5-47F7-A11C-6F7F995CF7A7Q55092124-566408C6-40B1-42FE-B5E7-0CF2125217C9Q55251613-538A5162-D6CD-4EA5-8ABB-3078B0217EAFQ55714688-58D3EE17-4E42-4492-87F3-7F76BC748057Q57903637-63351932-D756-4833-9961-293CA0ECD1A1Q58766967-5B77448C-483E-431F-A55C-63A194B1AECB
P2860
Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Gynecologic Cancer InterGroup ...... ne and ovarian carcinosarcoma.
@en
type
label
Gynecologic Cancer InterGroup ...... ne and ovarian carcinosarcoma.
@en
prefLabel
Gynecologic Cancer InterGroup ...... ne and ovarian carcinosarcoma.
@en
P2093
P50
P3181
P1476
Gynecologic Cancer InterGroup ...... ine and ovarian carcinosarcoma
@en
P2093
Andres Poveda
Dominique Berton-Rigaud
Isabelle Ray-Coquard
Jonathan A Ledermann
Mario M Leitao
Matthew A Powell
Mojgan Devouassoux-Shisheboran
Nicholas Simon Reed
Philip Beale
Philipp Harter
P304
P356
10.1097/IGC.0000000000000228
P433
P577
2014-11-01T00:00:00Z